Form 4: Dayforce Executive Jeffrey Jacobs Reports Stock Sale and Option Holdings
SEC Form 4 Filing
Jeffrey Jacobs, Head of Accounting and Financial Reporting at Dayforce, Inc., reports the sale of 376 shares of common stock and details holdings of common stock and stock options.
Summary
- Jeffrey Jacobs, Head of Accounting and Financial Reporting at Dayforce, Inc., filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- On October 1, 2024, Jacobs sold 376 shares of common stock at a price of $61.10 per share.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan.
- Following the transaction, Jacobs directly owns 34,217 shares of Dayforce, Inc. common stock.
- This includes shares acquired through the company's Global Employee Stock Purchase Plan (GESPP) on March 31, 2024 (139 shares), June 30, 2024 (218 shares), and September 30, 2024 (21 shares).
- Jacobs also holds options to purchase Dayforce common stock at various exercise prices and expiration dates, as well as performance units (PSUs) that will convert into common stock upon vesting.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Future Outlook
The number of shares issued from the PSUs may range from zero to 167% of the target number reported, based on the company's performance against metrics in the 2024 Management Incentive Plan.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the trading activities of company insiders. This filing indicates that a company executive is selling shares, which could be for personal financial planning reasons.
Stakeholder Impact
- The stock sale by an executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale.
- The filing provides transparency to stakeholders regarding insider trading activities.
Key Dates
| Date | Description |
|---|---|
| February 22, 2023 | Date the Reporting Person adopted the Rule 10b5-1 trading plan. |
| February 24, 2022 | Date of grant for 1,412 restricted stock units (RSUs), vesting on February 24, 2025. |
| February 24, 2022 | Date of grant for performance stock units (PSUs), vesting on February 24, 2025. |
| February 28, 2023 | Date of grant for 5,485 restricted stock units (RSUs), vesting in two tranches on February 28, 2025 and February 28, 2026. |
| March 31, 2024 | Date of acquisition of 139 shares under the Dayforce, Inc. Global Employee Stock Purchase Plan (GESPP). |
| March 1, 2024 | Date of grant for 14,652 restricted stock units (RSUs), vesting in three tranches on March 1, 2025, March 1, 2026, and March 1, 2027. |
| June 18, 2024 | Date the Reporting Person modified the Rule 10b5-1 trading plan. |
| June 30, 2024 | Date of acquisition of 218 shares under the Dayforce, Inc. Global Employee Stock Purchase Plan (GESPP). |
| September 30, 2024 | Date of acquisition of 21 shares under the Dayforce, Inc. Global Employee Stock Purchase Plan (GESPP). |
| October 01, 2024 | Date of the stock sale transaction. |
| October 03, 2024 | Date of the Form 4 filing. |
| December 08, 2025 | Expiration date for options to buy 500 shares of common stock. |
| December 31, 2026 | Expiration date for options to buy 1,125 shares of common stock. |
| December 20, 2027 | Expiration date for options to buy 5,000 shares of common stock. |
| April 25, 2028 | Expiration date for options to buy 32,610 shares of common stock. |
| February 08, 2029 | Expiration date for options to buy 712 shares of common stock. |
| March 20, 2029 | Expiration date for options to buy 8,396 shares of common stock. |
| May 08, 2030 | Expiration date for options to buy 14,299 shares of common stock. |
| February 24, 2032 | Vesting date for 1,176 Performance Units. |
| March 01, 2034 | Vesting date for 1,096 Performance Units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.